Nurieva N S, Shelegova I G, Fanakin V A
South Ural State Medical University, Chelyabinsk, Russia.
Stomatologiia (Mosk). 2024;103(4):33-36. doi: 10.17116/stomat202410304133.
Was to investigate the dynamics of mandibular density in cancer patients during therapy with zolendronic acid.
The study comprised 14 patients who received zolendronic acid at a dosage of 4 mg once every 28 days for bone metastases. In all 14 patients, measurements of mandibular density values on CT scans were performed over time.
Using multiple linear regression analysis, a model was developed to predict the effect of the number of zolendronic acid injections «X» on the dynamics of mandibular density «Y». The resulting formula for predicting mandibular density is Y = 5.9 X + 49 HU.
The model has limitations due to the study design but still can be used by oncologists and dentists to assess mandibular density in patients taking zolendronic acid.
旨在研究唑来膦酸治疗期间癌症患者下颌骨密度的变化动态。
该研究纳入了14例因骨转移接受唑来膦酸治疗的患者,剂量为4mg,每28天一次。对所有14例患者,随时间推移在CT扫描上测量下颌骨密度值。
采用多元线性回归分析,建立了一个模型来预测唑来膦酸注射次数“X”对下颌骨密度“Y”变化动态的影响。预测下颌骨密度的最终公式为Y = 5.9X + 49HU。
由于研究设计的原因,该模型存在局限性,但肿瘤科医生和牙医仍可使用它来评估服用唑来膦酸患者的下颌骨密度。